Replimune Group, Inc.
REPL
$9.27
$0.222.43%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 80.44M | 76.14M | 75.40M | 76.22M | 59.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 239.17M | 229.65M | 234.53M | 232.86M | 226.88M |
| Operating Income | -239.17M | -229.65M | -234.53M | -232.86M | -226.88M |
| Income Before Tax | -227.73M | -212.61M | -219.80M | -215.39M | -209.20M |
| Income Tax Expenses | 510.00K | 408.00K | 207.00K | 408.00K | 761.00K |
| Earnings from Continuing Operations | -228.24 | -213.02 | -220.01 | -215.79 | -209.96 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -228.24M | -213.02M | -220.01M | -215.79M | -209.96M |
| EBIT | -239.17M | -229.65M | -234.53M | -232.86M | -226.88M |
| EBITDA | -236.25M | -226.75M | -231.80M | -230.24M | -224.40M |
| EPS Basic | -3.25 | -3.16 | -3.28 | -3.24 | -3.16 |
| Normalized Basic EPS | -2.03 | -1.97 | -2.05 | -2.02 | -1.97 |
| EPS Diluted | -3.25 | -3.16 | -3.28 | -3.24 | -3.16 |
| Normalized Diluted EPS | -2.03 | -1.97 | -2.05 | -2.02 | -1.97 |
| Average Basic Shares Outstanding | 280.40M | 270.03M | 268.22M | 266.28M | 265.59M |
| Average Diluted Shares Outstanding | 280.40M | 270.03M | 268.22M | 266.28M | 265.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |